Johnson & Johnson (NYSE:JNJ) reported on Monday that its board of directors approved a common stock cash dividend of USD0.95 per share for the third quarter of 2019,the company .
With an ex-dividend date of 26 August 2019, the dividend will be paid on 10 September 2019 to shareholders of record at the close of business on 27 August 2019.
Johnson & Johnson together with its subsidiaries, researches and develops, manufactures and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical and Medical Devices.
The company was incorporated in 1887 and is based in New Brunswick, New Jersey, USA.
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Perrigo to pay quarterly dividend of USD0.290 per share
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
AstraZeneca strikes landmark drug pricing deal with US Government
Fusion Antibodies secures multi-target humanisation contract with global pharmaceutical client
Genmab to acquire Merus in USD8bn deal to strengthen oncology pipeline